These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 39568)

  • 1. Fluorimetric determination and pharmacokinetic studies of fazadinium bromide in dogs.
    Pastorino AM
    Arzneimittelforschung; 1978; 28(10):1728-30. PubMed ID: 39568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between pharmacokinetics and pharmacodynamics of fazadinium in rabbits.
    Dominguez-Gil AA; Cepeda M; Muriel C; Calvo JI; Dominguez-Gil A; Alonso AC
    Arzneimittelforschung; 1981; 31(11):1913-7. PubMed ID: 6119095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical neuromuscular pharmacology of AH 8165 D, an azobis-arylimidazo-pyridinium-compound.
    Schuh FT
    Anaesthesist; 1975 Apr; 24(4):151-6. PubMed ID: 237423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of besulpamide in rats and dogs.
    Esteve J; Martínez L; Roser R; Sagarra R
    Methods Find Exp Clin Pharmacol; 1987 Feb; 9(2):121-6. PubMed ID: 3586769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolism of fazadinium bromide [proceedings].
    Bell JA; Martin LE
    Br J Pharmacol; 1979 Jul; 66(3):433P. PubMed ID: 43175
    [No Abstract]   [Full Text] [Related]  

  • 6. Factors limiting the rate of termination of the neuromuscular blocking action of fazadinium dibromide.
    Tyers MB
    Br J Pharmacol; 1978 Jun; 63(2):287-93. PubMed ID: 27272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of fazadinium in man.
    Duvaldestin P; Henzel D; Demetriou M; Desmonts JM
    Br J Anaesth; 1978 Aug; 50(8):773-7. PubMed ID: 28133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preliminary report on the AH 8.165 (1-1'azo bis-3-methyl-2-phenyl-1H-imidazo 1,2-A) pyridinium dibromate].
    Dávalos Sánchez R; Belda Mendoza J; Salort Vives J
    Rev Esp Anestesiol Reanim; 1978 Jan; 25(1):68-73. PubMed ID: 30120
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics of fazadinium in patients with renal failure.
    Duvaldestin P; Bertrand JC; Concina D; Henzel D; Lareng L; Desmonts JM
    Br J Anaesth; 1979 Oct; 51(10):943-7. PubMed ID: 42420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical model of some pharmacokinetic and pharmacodynamic properties of fazadinium in man.
    d'Hollander AA; Delcroix C; Duvaldestin P; Henzel D; Coussaert E; Desmonts JM
    Eur J Clin Pharmacol; 1983; 24(3):407-13. PubMed ID: 6134623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A new non-depolarizing relaxant agent: AH 8165 D (fazadinium dibromide)].
    Cabarrocas Gafarot E; Barbero Carballo MC; Cortés Forteza C; Rodríguez Moñinos A; Comas Arroyo ML
    Rev Esp Anestesiol Reanim; 1979 Mar; 26(2):99-110. PubMed ID: 38489
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuromuscular blockade of fazadinium bromide (AH 8165) in renal failure patients.
    Camu F; D'Hollander A
    Acta Anaesthesiol Scand; 1978; 22(3):221-6. PubMed ID: 27936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between decay of plasma concentration of fazadinium and recovery from its neuromuscular blocking effect.
    d'Hollander AA; Duvaldestin P; Henzel D; Delcroix C; Desmonts JM
    Br J Anaesth; 1981 Aug; 53(8):853-8. PubMed ID: 6115662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fazadinium pharmacokinetics in patients with liver disease.
    Duvaldestin P; Saada J; Henzel D; Saumon G
    Br J Anaesth; 1980 Aug; 52(8):789-94. PubMed ID: 6107098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of fazadinium.
    Bevan DR; D'Souza J; Rouse JM; Caldwell J; Smith RL
    Anaesthesia; 1980 Sep; 35(9):873-8. PubMed ID: 6108730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of impaired renal function on the disposition of [14C]fazadinium in the anaesthetized greyhound [proceedings].
    Bevan DR; Caldwell J; D'Souza J; Smith RL
    Br J Pharmacol; 1978 Nov; 64(3):402P-403P. PubMed ID: 31217
    [No Abstract]   [Full Text] [Related]  

  • 17. [A new non-depolarizing muscle relaxant. Initial clinical experiences with fazadinium bromide].
    Beltrutti D; Pellegrino R; Alessandrini A; Cussino R
    Minerva Anestesiol; 1982 Mar; 48(3):121-5. PubMed ID: 6124902
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacology of fazadinium (AH 8165)].
    Kienlen J; du Callar J
    Ann Anesthesiol Fr; 1981; 22(6):631-9. PubMed ID: 6124193
    [No Abstract]   [Full Text] [Related]  

  • 19. [Influence of serum proteins on the action of fazadinium bromide].
    Macoretta P; Poletto TA; Paciello F
    Ann Osp Maria Vittoria Torino; 1982; 25(1-6):46-53. PubMed ID: 6136251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An automated fluorimetric method for the determination of fluproquazone in plasma and urine.
    Pacha W; Delaborde C; Keller HP; Meier J; Rietsch H
    Arzneimittelforschung; 1981; 31(5a):893-6. PubMed ID: 6973982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.